IPRIPR2022-00125Final Written Decision
Hope Medical Enterprises, Inc.v.Fennec Pharmaceuticals, Inc.
IPR challenge of US 10792363.
Type
IPR
Filed
Oct 29, 2021
Instituted
May 16, 2022
Decided
Sep 1, 2023
Patent
Application
16458261
Inventor
Thomas Claiborne LOVELACE et al
Granted
Oct 6, 2020
01
Timeline
3 milestones
2021-10-29Petition filed
2022-05-16Institution
2023-09-01Terminated
02
Parties & counsel
Petitioner
Hope Medical Enterprises, Inc.
Counsel
Johnson, Matthewet al
Patent Owner
Fennec Pharmaceuticals, Inc.
Counsel
Knowles, Sherryet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →